From Johnson's lactic acid strain, CNCM I-1225, acidic lactic acid production efficiency is low, service life is improved； enzyme D-Lactato dehydrogenase from its amniotic fluid into Arg position 77； used to treat or prevent SIST-related disorders Emma's immunity is weak.
FOATA FRANCIS,DELLEY MICHELE,JANKOVIC IVANA,PRIDMORE RAYMOND DAVID
申请号：
CL2013002760
公开号：
CL2013002760A1
申请日:
2013.09.26
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
The present invention generally relates to the field of probiotic bacteria. In particular, the present invention relates to natural derivatives of the Lactobacillus johnsonii strain CNCM I-1225 with improved properties. For example, the present invention relates to a natural derivative of the Lactobacillus johnsonii strain CNCM I-1225 that is deficient in D-lactic acid production and exhibits an improved viability during product storage.DERIVADO DE LA CEPA LACTOBACILLUS JOHNSONII, CNCM I-1225, DEFICIENTE EN LA PRODUCCION DE ACIDO D-LACTICO Y CON UNA VIDA UTIL MEJORADA； DONDE LA ENZIMA D-LACTATO DESHIDROGENASA TIENE UN CAMBIO DE AMNOACIDOS DE HIS POR ARG EN LA POSICION 77； USOS PARA TRATAR O PREVENIR TRASTORNOS VINCULADOS A UN SISTEMA INMUNE DEBILITADO.
